Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 20/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10087251 | 0.89 | CNR1 (0.65) | CNR1 | |
| SCHEMBL4633715 | 0.89 | CNR1 (0.63) | CNR1 | |
| Hydrochloric Acid SCHEMBL8018664 | 0.88 | CNR1 (0.62) | CNR1 | |
| SCHEMBL4634228 | 0.88 | CNR1 (0.69) | CNR1 | |
| SCHEMBL2679126 | 0.85 | CNR1 (0.65) | CNR1 | |
| SCHEMBL14161984 | 0.84 | CNR1 (0.59) | CNR1 | |
| SCHEMBL2063699 | 0.84 | CNR1 (1.00) | CNR1 | |
| SCHEMBL27646546 | 0.83 | CNR1 (0.55) | CNR1 | |
| SCHEMBL3821972 | 0.83 | CNR1 (0.69) | CNR1 | |
| SCHEMBL14214779 | 0.82 | CNR1 (1.00) | CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121617-B1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA AS (DK) | 2014-01-22 | — | — | EP | disclosed |
| EP-2121617-B1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA AS (DK) | 2014-01-22 | — | — | EP | disclosed |
| EP-2121659-B1 | MODULATORS OF CB1 RECEPTORS | 7TM PHARMA AS (DK) | 2013-05-15 | — | — | EP | disclosed |
| EP-2121659-B1 | MODULATORS OF CB1 RECEPTORS | 7TM PHARMA AS (DK) | 2013-05-15 | — | — | EP | disclosed |
| US-8173680-B2 | Cannabinoid receptor modulators | 7TM PHARMA A/S (DK) | 2012-05-08 | — | — | US | disclosed |
| US-8173680-B2 | Cannabinoid receptor modulators | 7TM PHARMA A/S (DK) | 2012-05-08 | — | — | US | disclosed |
| US-8148404-B2 | Modulators of CB1 receptors | 7TM PHARMA A/S (DK) | 2012-04-03 | — | — | US | disclosed |
| US-8148404-B2 | Modulators of CB1 receptors | 7TM PHARMA A/S (DK) | 2012-04-03 | — | — | US | disclosed |
| US-8148404-B2 | Modulators of CB1 receptors | 7TM PHARMA A/S (DK) | 2012-04-03 | — | — | US | disclosed |
| US-8124634-B2 | CB1 receptor modulators | 7TM PHARMA A/S (DK) | 2012-02-28 | — | — | US | disclosed |
| EP-2094666-A1 | CANNABINOID RECEPTOR MODULATORS | 7TM Pharma A/S (DK) | 2009-09-02 | — | — | EP | disclosed |
| WO-2009074782-A1 | CANNABINOID RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2009-06-18 | — | — | WO | disclosed |
| WO-2009074782-A1 | CANNABINOID RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2009-06-18 | — | — | WO | disclosed |
| US-20080200527-A1 | Cannabinoid Receptor Modulators | CAREX SA (FR) | 2008-08-21 | — | — | US | disclosed |
| WO-2008075012-A1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008075013-A1 | MODULATORS OF CANNABINOID RECEPTOR | 7TM PHARMA A/S (DK) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008075019-A1 | MODULATORS OF CB1 RECEPTORS | 7TM PHARMA A/S (DK) | 2008-06-26 | — | — | WO | disclosed |
| EP-1928859-A1 | PYRAZOLE DERIVATES AS CANNABINOID RECEPTOR MODULATORS | Carex SA (FR) | 2008-06-11 | — | — | EP | disclosed |
| WO-2008059207-A1 | CANNABINOID RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2008-05-22 | — | — | WO | disclosed |
| WO-2006133926-A1 | PYRAZOLE DERIVATES AS CANNABINOID RECEPTOR MODULATORS | CAREX SA (FR) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200527-A1 | Cannabinoid Receptor Modulators | CNR1, CNR2, HCRTR2 | CNR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.